Soligenix Completes Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohn's Disease

PRINCETON N.J. June 28 2013 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains a...